BOT 2.63% 37.0¢ botanix pharmaceuticals ltd

BOT - Anything but charting, page-8736

  1. 2,062 Posts.
    lightbulb Created with Sketch. 1479
    Kaken have rights to sell in Japan, South Korea, China and other certain Asian countries. China alone will be worth millions in royalties, but keep it small if you wish.
 
watchlist Created with Sketch. Add BOT (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.